简体中文
English
Website review
This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.
What is Evergen?
Evergen is a global contract development and manufacturing organization (CDMO) focused on regenerative medicine. It partners with original equipment manufacturers (OEMs) to design, develop, and manufacture customized biomaterial solutions, including allograft and xenograft materials, used in surgical and clinical applications.
Its stated approach is patient-first: it starts from a clinical need, then selects and processes biomaterials intended to support the body’s natural healing, speed recovery, and reduce complications. The company reports deep expertise in plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine, and cardiac applications.
Who it serves
- OEMs and innovators that need a manufacturing and development partner rather than an off-the-shelf product
- Surgical and clinical teams indirectly, through the implants and therapies its customers bring to market
What it offers
- Custom biomaterial design and development
- Allograft and xenograft materials
- Material and process technologies
- Commercial-ready manufacturing and donor services
Track record it highlights
- Founded in 1998
- More than 20 million implants delivered
- More than 200 market authorizations
- More than 50 510(k) clearances
If you are evaluating Evergen as a partner, a useful next step is to compare your specific application—material type, clinical area, and regulatory pathway—against its listed capabilities, then request a direct conversation about development timelines and manufacturing fit.
How does Evergen support OEMs in developing regenerative medicine products?
Evergen supports OEMs as a contract development and manufacturing organization (CDMO) focused on regenerative biomaterials. Rather than selling a fixed catalog, it works with OEM partners to design, develop and manufacture customized allograft and xenograft solutions, starting from the clinical need and the patient's surgical requirements.
What the partnership covers
- Custom development: Tailored biomaterial solutions matched to a specific device, procedure or surgical need.
- Materials and process expertise: The site groups its offering into biomaterials, material technologies and process technologies, so an OEM can draw on both the material choice and the manufacturing method.
- Commercial-ready manufacturing: It describes commercial-ready options and donor services, which matters for partners moving from design into scaled supply.
- Clinical depth: Stated expertise spans plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine and cardiac.
Track record as a decision signal
The page cites more than 20 million implants, over 200 market authorizations and more than 50 510(k) clearances since its founding in 1998. For an OEM, those numbers are most useful as evidence of regulatory and manufacturing experience across many product programs, not as a guarantee for any single new project.
How to judge fit
| Your situation | Why Evergen may or may not fit |
|---|---|
| You need a custom allograft or xenograft component | Aligns with its stated model of co-developing tailored biomaterials |
| You need a partner with regulatory submission history | Relevant given the cited authorizations and clearances |
| You need a standard off-the-shelf material quickly | Less clear; the emphasis is on partnership and customization |
| Your application sits outside its named clinical areas | Worth confirming directly, since the listed areas are specific |
Next step: before contacting them, write a one-page brief covering the clinical need, target anatomy, required material properties, regulatory pathway and expected annual volume. Ask specifically which material and process technologies apply to your case, what development phases and timelines look like, and who owns the resulting intellectual property. That gives you a concrete basis for comparing Evergen with other CDMOs such as [[site:cam Biologics.com|Cambiologics]] or your existing suppliers.
What types of biomaterials does Evergen offer?
Evergen supplies allograft and xenograft biomaterials — human- and animal-derived tissue — rather than synthetic or purely polymer-based implants. The site frames these as customizable inputs for original equipment manufacturers (OEMs), not as off-the-shelf products sold directly to clinicians or patients.
What that means in practice
- Allograft biomaterials: tissue donated by humans, processed for implantation. In regenerative medicine these are commonly used as structural scaffolds, grafts or fillers where the goal is to support the body's own healing rather than replace tissue permanently.
- Xenograft biomaterials: tissue of animal origin, processed for human clinical use. These typically serve similar scaffolding or graft roles where a human donor source is not available or not preferred.
Evergen describes the materials as supporting the body's natural healing process and as suitable for a wide range of clinical applications. Its stated areas of clinical expertise are plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine and cardiac — so the biomaterials are positioned around those procedure types rather than consumer or veterinary markets.
How the offering is structured
| Layer | What Evergen provides |
|---|---|
| Material source | Allograft and xenograft tissue |
| Technology focus | Material technologies and process technologies |
| Service model | Custom design, development and manufacturing for OEM partners |
| Output | Finished regenerative biomaterial solutions tailored to a partner's requirements |
Who this is for
The direct audience is an OEM or device company that needs a biomaterial component developed and manufactured to its own specification. A clinician or patient looking to buy a graft would not find a purchasing path here; the relevant decision-maker is a product or sourcing team at a medical device firm. Evergen presents itself as a contract development and manufacturing organization (CDMO), so the relationship is a development and supply partnership rather than a catalogue transaction.
Next step
If you are evaluating Evergen as a potential manufacturing partner, the useful question is not "which materials exist" but "can they process the specific tissue type, form factor and regulatory pathway my product needs." The site's Material Technologies and Process Technologies pages, plus the Services section, are where that detail would live. For a broader view of how allograft and xenograft suppliers present themselves, compare with an established regenerative medicine manufacturer such as RTI Surgical or a tissue bank network like American Association of Tissue Banks for standards context.
What clinical specialties does Evergen serve?
Evergen serves four clinical areas, based on the specialties listed on its site: plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine, and cardiac.
Its work in these areas centers on customized allograft and xenograft biomaterials for OEM partners, rather than finished devices sold under its own brand. The company describes itself as a global CDMO that designs, develops, and manufactures regenerative biomaterial solutions intended to support the body's natural healing process across a range of procedures.
How the specialties differ in practice
- Plastic and reconstructive surgery — typically involves soft-tissue support and reconstruction, where material handling and integration with surrounding tissue matter.
- Sports medicine and orthopedics — often focuses on repair and recovery timelines, so material selection tends to prioritize load-bearing or healing-support roles.
- Neuro/spine — generally the most exacting in terms of consistency and clinical evidence, given the sensitivity of the anatomy involved.
- Cardiac — a smaller, highly specialized area where material performance requirements differ substantially from orthopedic use.
A practical next step
If you are evaluating Evergen as a potential manufacturing partner, match your program to the specialty list first, then ask which biomaterial and process technologies they apply in that specific area. A company can serve a specialty broadly while having deeper capability in particular material types, so the specialty list alone will not tell you whether your exact application is a good fit.
What are Evergen's manufacturing capabilities and credentials?
Evergen is a global contract development and manufacturing organization (CDMO) focused on regenerative biomaterials, so its manufacturing story is less about selling a catalog product and more about building custom allograft and xenograft solutions for original equipment manufacturers (OEMs). Its stated capabilities span material technologies and process technologies, with commercial-ready options and donor services feeding into that pipeline. In practice, that means an OEM can bring a clinical need or product concept and work with Evergen on biomaterial selection, design, development and manufacturing rather than sourcing a generic material.
Credentials and scale According to the site, Evergen was founded in 1998 and has since delivered more than 20 million implants, over 200 market authorizations and more than 50 510(k) clearances. It also highlights manufacturing sites and credentials as part of its corporate profile. Those figures are the clearest public signals of regulatory experience and production volume: the 510(k) count points to a track record with the US FDA's premarket notification pathway, while the market authorizations suggest broader international reach.
Where the capabilities fit The site names deep clinical expertise in plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine and cardiac. For a reader evaluating a manufacturing partner, that matters because biomaterial behavior is procedure-specific: a material that suits a soft-tissue reconstructive application may not meet the mechanical or handling demands of a spine or cardiac device. Evergen's pitch is that it selects and processes biomaterials around those individual surgical needs.
How to judge the fit If you are an OEM or a clinician-entrepreneur, the practical test is whether your target application matches one of those named clinical areas and whether you need allograft, xenograft or both. The next step is to request the specific site credentials and quality certifications behind the "Manufacturing Sites & Credentials" page, then compare them against your regulatory pathway. For general context on regenerative medicine manufacturing, U.S. Food and Drug Administration publishes relevant guidance, and ASTM International maintains standards for biomaterials and medical devices.
What career opportunities are available at Evergen?
Evergen presents itself as a global contract development and manufacturing organization (CDMO) focused on regenerative medicine biomaterials, and its careers section is framed around that mission: values-driven work, quality, innovation, and a patient-first culture. The page does not list individual job titles or departments, so the most reliable way to see current openings is to visit the Careers section directly on Evergen.
What the site indicates about working there
- The company describes its people as driving quality, innovation, and collaboration.
- It emphasizes a patient-first approach and partnerships with OEMs to design, develop, and manufacture customized biomaterial solutions.
- Its stated clinical areas include plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine, and cardiac.
- The page also references manufacturing sites and credentials, which suggests roles may span both corporate and site-based operations.
Practical next step
If you are job hunting, start with the Careers page and look for openings that match your background. Given the CDMO model, likely areas of work could include manufacturing and process roles, quality and regulatory affairs, research and development, clinical or medical affairs, and commercial or partnership-facing positions. The site does not confirm which of these are currently open, so treat that as a guide rather than a list of vacancies.
Example decision criterion
If you want a patient-impact role in a manufacturing or development environment, Evergen's emphasis on biomaterials and OEM partnerships may fit well. If you are looking for a purely academic research post, a large hospital system, or a consumer-facing medtech brand, the fit may be different.
Cloudflare
Microsoft 365
User reviews (0)